Sfoglia per RIVISTA
TRANSLATIONAL LUNG CANCER RESEARCH
Collezione AOU Città della Salute di Torino
Items : 3
Osimertinib versus comparator first-generation epidermal growth factor receptor tyrosine kinase inhibitors as first-line treatment in patients with advanced EGFR-mutated non-small cell lung cancer: a Chinese, multicenter, real-world cohort study. in Translational lung cancer research / Transl Lung Cancer Res. 2023 Nov 30;12(11):2229-2244. doi: 10.21037/tlcr-23-577. Epub 2023 Oct 26.
2023
AOU Città della Salute di Torino
Chen X; Zhang S; Gu Y; Tang Y; Mu X; Qin J; Yang X; He M; Liu Y; Zhong W; Gao J; Chen M; Zhao J; Gao X; Liu J; Zhang H; Shi Y; Zhao D; Shen F; Liu X; Zhang D; Pang L; Meng Q; Guo Y; Zhang Y; Li W; Xing P; Cheng Y; Xin T; et alii...
Future perspectives from lung cancer pre-clinical models: new treatments are coming? in Translational lung cancer research / Transl Lung Cancer Res. 2020 Dec;9(6):2629-2644. doi: 10.21037/tlcr-20-189.
2020
AOU San Luigi di Orbassano
AOU Città della Salute di Torino
Righi L; Bironzo P; Tabbò F; Morotti A; Picca F; Morena D; Bersani F; Taulli R;
Classification of pulmonary neuroendocrine tumors: new insights. in Translational lung cancer research / Transl Lung Cancer Res. 2017 Oct;6(5):513-529. doi: 10.21037/tlcr.2017.09.04.
2017
AOU Città della Salute di Torino
Pelosi G; Sonzogni A; Harari S; Albini A; Bresaola E; Marchiò C; Massa F; Righi L; Gatti G; Papanikolaou N; Vijayvergia N; Calabrese F; Papotti M;